Aktienanalyse wird geladen …
SOLV · NYSE · Medical Devices · USA
88,57 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 8,33 Mrd. | 1,56 Mrd. | 8,88 $ | 175,3 Mio. | 1,8 Mio · 1 % | 0,2 Mio · 0,1 % | 53,5 % | 18,7 % | -0,06 $ | 0,92 $ | — |
| 2024 | 8,25 Mrd. | 479 Mio. | 2,76 $ | 173,7 Mio. | 1,3 Mio · 0,7 % | 0,3 Mio · 0,2 % | 55,7 % | 5,8 % | 4,63 $ | 0,64 $ | — |
| 2023 | 8,2 Mrd. | 1,35 Mrd. | 7,79 $ | 172,7 Mio. | 0,4 Mio · 0,3 % | 0,4 Mio · 0,3 % | 57,3 % | 16,4 % | 9,41 $ | 0,23 $ | — |
| 2022 | 8,13 Mrd. | 1,34 Mrd. | 7,78 $ | 172,7 Mio. | 0,4 Mio · 0,2 % | — | 57,8 % | 16,5 % | 8,27 $ | 0,21 $ | — |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,21 Mrd. | 92 Mio. | 0,53 $ | 173,3 Mio. | 58,2 % | 4,2 % | 0,83 $ |
| Q1 2026 | 2,01 Mrd. | 13 Mio. | 0,07 $ | 175,5 Mio. | 54,7 % | 0,7 % | -1,56 $ |
| Q4 2025 | 2 Mrd. | 63 Mio. | 0,36 $ | 175,7 Mio. | 51,4 % | 3,2 % | 0,18 $ |
| Q3 2025 | 2,1 Mrd. | 1,27 Mrd. | 7,22 $ | 175,4 Mio. | 54,2 % | 60,4 % | -0,12 $ |
| Q2 2025 | 2,16 Mrd. | 90 Mio. | 0,51 $ | 175,2 Mio. | 54,4 % | 4,2 % | 0,34 $ |
| Q1 2025 | 2,07 Mrd. | 137 Mio. | 0,78 $ | 174,8 Mio. | 53,8 % | 6,6 % | -0,46 $ |
| Q4 2024 | 2,08 Mrd. | 31 Mio. | 0,18 $ | — | 53,9 % | 1,5 % | 0,52 $ |
| Q3 2024 | 2,08 Mrd. | 122 Mio. | 0,70 $ | 173,9 Mio. | 56 % | 5,9 % | 0,44 $ |
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
What Solventum (SOLV)'s Earnings Beat and Surgical AI Push Means For Shareholders
Q2 Surgical Equipment & Consumables - Diversified Earnings: Solventum (NYSE:SOLV) Impresses
Solventum (SOLV) Up 11.4% Since Last Earnings Report: Can It Continue?
Solventum Corporation is a healthcare company that develops and commercializes a broad portfolio of products and software designed to address clinical and operational needs across care settings. Its Medsurg business provides wound care, skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, and medical electrodes. The Dental Solutions segment offers products used in restorative and orthodontic workflows, including brackets, aligners, cements, and bonding agents. Through Health Information Systems, Solventum supplies software and services that support physician documentation, coding automation, speech recognition, and data visualization for healthcare organizations. The company serves customers in the United States and internationally through direct sales, distribution, key account management, inside sales, and e-commerce. Headquartered in Eagan, Minnesota, Solventum focuses on technologies that support safer, more efficient healthcare delivery.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest SOLV und jede andere Aktie unbegrenzt.